Core Viewpoint - HSSP INTL (03626) has established a joint venture with Coty Holding Ltd to distribute brand electronic cigarette devices in the UAE, with HSSP holding a 30% stake and Coty holding 70% [1][2] Group 1: Joint Venture Details - The joint venture will be formed through HSSP's wholly-owned subsidiary, East Nova Limited, and will require confirmation from UAE legal advisors before becoming official [1] - East Nova and Coty will invest 90,000 AED (approximately 190,000 HKD) and 210,000 AED (approximately 440,000 HKD) respectively into the joint venture [1] Group 2: Strategic Intent and Market Position - The establishment of the joint venture aims to provide a strong platform for HSSP's electronic cigarette business and capitalize on market opportunities [2] - Coty is a diversified investment holding company based in Dubai, with strategic interests across nicotine alternatives, technology, and retail sectors [2] - Coty oversees leading platforms in the GCC region, including ANDS, a leader in nicotine alternative distribution, and Smokers Center, a retail chain focused on next-generation nicotine products [2] Group 3: Expansion Plans - HSSP's wholly-owned subsidiary, Alpha Six Three Limited, has signed a professional services agreement with an independent service provider to manage the registration and import of "HEAPS" brand electronic cigarette products in Australia [2] - This move follows Alpha Six Three's establishment of a subsidiary in New Zealand in November 2024 to sell electronic cigarette devices [2]

Core Viewpoint - Huachuang Securities maintains a "strong buy" rating for Smoore International (06969) with a target price of HKD 21.90, highlighting the company's leading position in the global electronic vaporization market and potential for growth in both e-cigarette and HNB (Heated Not Burned) businesses [1] Group 1: Financial Performance - In the first three quarters, the company achieved revenue of CNY 10.21 billion, a year-on-year increase of 21.8%, while net profit was CNY 809 million, a decrease of 23.8%. Adjusted net profit was CNY 1.182 billion, a slight increase of 0.1% [1] - For Q3 alone, the company reported revenue of CNY 4.197 billion, a year-on-year increase of 27.2%, and net profit of CNY 317 million, down 16.4%. Adjusted net profit for the quarter was CNY 444 million, up 4.0% year-on-year [1] Group 2: HNB Product Growth - The market feedback for HNB products is positive, with significant increases in product shipments contributing to impressive revenue growth. The Glo Hilo product has received praise for its stylish design and flavor delivery compared to IQOS [2] - As Glo Hilo expands in the European market, the product penetration rate is expected to accelerate [2] Group 3: E-Cigarette Business and Regulatory Environment - The company benefits from stricter regulations on non-compliant products globally, with a recent poll indicating that 80% of U.S. voters support increased enforcement against illegal e-cigarettes, which may help the company's business recovery [3] - The company's own brand performance remains strong due to the launch of flagship new products and enhanced localized operations [3] Group 4: Profitability and Cost Management - The adjusted net profit margin for Q3 was approximately 10.6%, a decrease of 2.4 percentage points year-on-year, primarily due to the product mix with a higher proportion of lower-margin HNB products in early sales [4] - The company has seen steady improvement in sales, management, and R&D expense ratios, which is expected to enhance profit flexibility in the future [4]

Core Viewpoint - Huachuang Securities maintains a "strong buy" rating for Smoore International (06969) with a target price of HKD 21.90, highlighting the company's leading position in the global electronic vaporization market and potential for growth in both e-cigarette and HNB (Heated Not Burned) segments [1] Group 1: Financial Performance - In Q3 2025, the company reported revenue of CNY 10.21 billion, a year-on-year increase of 21.8%, while net profit was CNY 809 million, a decrease of 23.8%. Adjusted net profit stood at CNY 1.18 billion, a slight increase of 0.1% [1] - For Q3 alone, revenue reached CNY 4.197 billion, up 27.2% year-on-year, with net profit at CNY 317 million, down 16.4%. Adjusted net profit for the quarter was CNY 444 million, reflecting a 4.0% increase year-on-year [1] Group 2: HNB Product Growth - The market feedback for HNB products has been positive, with significant increases in product shipments contributing to impressive revenue growth. The Glo Hilo product has received favorable comparisons to IQOS, particularly for its design and flavor delivery [2] - As Glo Hilo expands in the European market, the product penetration rate is expected to accelerate [2] Group 3: Vaporization Business and Regulatory Environment - The vaporization business is benefiting from stricter regulations on non-compliant products globally, with a recent survey indicating that 80% of U.S. voters support enhanced enforcement against illegal e-cigarettes, which may help the company's business recovery [3] - The company's own brand performance has shown steady growth, aided by the launch of flagship products and enhanced local operations [3] Group 4: Profitability and Cost Management - The adjusted net profit margin for Q3 2025 was approximately 10.6%, a decrease of 2.4 percentage points year-on-year, primarily due to the product mix with a higher proportion of lower-margin HNB devices in early sales [4] - The company has seen steady improvements in sales, management, and R&D expense ratios, which are expected to enhance profit flexibility in the future [4]

Summary of Ispire Technology Conference Call (October 21, 2025) Company Overview - **Company**: Ispire Technology (NasdaqCM:ISPR) - **Industry**: Vaping devices, including e-cigarettes and cannabis-related products - **Revenue**: $127 million for the last fiscal year ending June [3] Core Business Focus - **Key Areas**: - Global e-cigarette industry - Vaping devices related to cannabis and CBD [2] - **Market Position**: Historically, the company was the number one selling brand in the U.S. until 2016 [4] Revenue Distribution - **Geographic Revenue Breakdown**: - Europe: ~50% - North America: ~40% - Rest of the World: Remaining revenue [5] Key Pillars of Business Strategy 1. **Age Verification Technology**: - Developed a blockchain-based age verification system to prevent underage access to e-cigarettes [14] - FDA has shown strong interest in this technology, suggesting it could be a solution for flavored e-cigarettes [19][21] - The technology has a 100% success rate in age verification trials [20] 2. **Manufacturing in Malaysia**: - Established factories in Malaysia to mitigate trade barriers and secure a nicotine manufacturing license [28] - Plans for a third factory to expand production capacity [27] 3. **Innovative Product Development**: - Introduced "g mesh technology" to replace ceramic cores in e-cigarettes, enhancing safety by preventing particle breakdown [32] - Engaging with major tobacco companies for potential manufacturing deals [33] 4. **Focus on High-Quality Cannabis Clients**: - Shifted strategy to prioritize financially stable cannabis customers amid regulatory uncertainties [34] Regulatory Environment - **FDA Involvement**: - The FDA's PMTA process requires products to meet safety and marketing standards before sale [11] - Current legal e-cigarette products account for less than 10% of total sales, with the majority coming from the illicit market [13][37] Market Dynamics - **Illicit Market Concerns**: - The illicit market for e-cigarettes is nine times larger than the legal market in the U.S. [37] - The age verification technology aims to address both adult consumer needs for flavored products and prevent youth access [38] Global Expansion Efforts - **International Engagement**: - Actively pursuing age verification technology adoption in various countries, including potential mandates in the UK [25] - Engaging with democratic countries for faster implementation of age gating [24] Conclusion - **Outlook**: The company is optimistic about the FDA's fast-tracked review of its age verification technology and is actively engaging with major tobacco players for licensing opportunities [22][23]

Core Viewpoint - Zheshang Securities maintains a "Buy" rating for Smoore International (06969), projecting significant revenue and profit growth from 2025 to 2027 [1] Financial Projections - Expected revenue for Smoore International: - 2025: 14.175 billion - 2026: 16.689 billion - 2027: 19.495 billion - Year-on-year growth: +20.14%, +17.73%, +16.81% [1] - Expected net profit attributable to shareholders: - 2025: 1.08 billion - 2026: 1.934 billion - 2027: 2.652 billion - Year-on-year growth: +17.15%, +79.13%, +37.10% [1] Market Dynamics - British American Tobacco is increasing resources and marketing efforts for Glo Hilo, with positive sales feedback in Japan and early deployment in some European countries [1] - The regulatory crackdown on illegal vaping products is expected to lead to a recovery in the vaping market, which bodes well for core supplier Smoore International [1]

Investment Rating - The investment rating for the company is "Buy" [5] Core Insights - The company reported Q3 2025 revenue of 4.2 billion HKD, a year-on-year increase of 27.2%, achieving a historical high for quarterly revenue, while profit was 317 million HKD, down 16.4% [1] - The company announced a new stock incentive plan, granting stock options and reward shares to employees, indicating ongoing commitment to employee motivation [1] - HNB product shipments have significantly increased, with positive feedback on the Glo Hilo product in Japan, and plans for expansion into European markets [2] - The ODM business has shown growth due to increased compliance orders, while the self-branded products have successfully iterated flagship offerings and improved local marketing efforts [3] - The company is expected to benefit from the regulatory crackdown on illegal products in the vaping industry, leading to a recovery in the market [4] Financial Summary - The company is projected to achieve revenues of 141.75 billion HKD, 166.89 billion HKD, and 194.95 billion HKD for 2025, 2026, and 2027 respectively, with year-on-year growth rates of 20.14%, 17.73%, and 16.81% [4][11] - The net profit attributable to the parent company is expected to be 10.80 billion HKD, 19.34 billion HKD, and 26.52 billion HKD for the same years, with growth rates of -17.15%, 79.13%, and 37.10% [4][11] - The current market capitalization is approximately 96.43 billion HKD, with a closing price of 15.57 HKD per share [5]

Core Viewpoint - The company's performance in Q3 2025 aligns with expectations, showing a revenue increase but a decline in net profit due to stock incentive expenses and ongoing high R&D investments [1][2]. Financial Performance - Revenue for the first three quarters of 2025 reached 10.21 billion yuan, a year-on-year increase of 21.8% - Net profit attributable to shareholders was 810 million yuan, a year-on-year decrease of 23.8% - Adjusted net profit after stock incentive expenses was 1.18 billion yuan, a slight increase of 0.1% [1]. Development Trends - Glo Hilo is expanding steadily in Japan and Poland, with positive sales momentum in the European vaping market - The company expects to see growth in revenue from HNB products and compliant vaping products in Europe, despite regulatory challenges in the U.S. [1][2]. Short-term Profitability and R&D - Short-term profitability may be slightly pressured due to increased orders from small clients in Europe and initial sales of HNB heating devices - The company is increasing R&D investments in vaping medical and HNB new businesses, which may impact net profit in Q3 2025 [2]. Long-term Growth Prospects - The company anticipates accelerated global expansion of Glo Hilo by 2026, which is expected to drive revenue growth - The vaping medical segment is expected to commercialize, opening up long-term growth opportunities [2]. Profit Forecast and Valuation - The forecast for net profit attributable to shareholders in 2025 has been reduced by 20% to 1.05 billion yuan, while the 2026 forecast has been increased by 11% to 1.88 billion yuan - The current stock price corresponds to a 47 times P/E ratio for 2026, with a target price maintaining a 69 times P/E ratio, indicating a potential upside of 46% [2].

Core Viewpoint - The report from CICC indicates a downward adjustment of 20% in the forecast for Smoore International's (06969) 2025 net profit attributable to shareholders, bringing it to 1.05 billion yuan, while the 2026 net profit forecast is raised by 11% to 1.88 billion yuan, reflecting a positive outlook driven by HNB product sales [1] Group 1: Financial Performance - For the first three quarters of 2025, the company reported revenue of 10.21 billion yuan, a year-on-year increase of 21.8%, while net profit attributable to shareholders was 810 million yuan, a decrease of 23.8%. Adjusted net profit after accounting for stock incentive expenses was 1.18 billion yuan, showing a slight increase of 0.1% [2] - Quarterly net profit figures for 2025 were 200 million yuan in Q1, 300 million yuan in Q2, and 317 million yuan in Q3, with year-on-year changes of -43.4%, +12.7%, and -16.4% respectively, aligning with CICC's expectations [2] Group 2: Market Expansion and Product Development - The Glo Hilo brand is expanding steadily in Japan and Poland, with the company positioned as a leader in flavor restoration, heating speed, and brand image. The positive sales momentum of heating devices is expected to contribute to revenue [3] - The company anticipates continued growth in the European vaping market, driven by differentiated compliant products from small brands, while orders in the U.S. are expected to remain stable despite regulatory tightening [3] - The company is leading in global market share for open-system proprietary brands, with expectations of continued year-on-year growth in Q3 2025 [3] Group 3: Profitability and R&D Investment - Short-term profitability may be slightly pressured due to increased orders from small customers in the European vaping market and initial sales of HNB heating devices. However, profitability is expected to improve as orders for vaping products increase and high-margin HNB products gain traction [4] - The company is increasing R&D investments in vaping medical and HNB new businesses, which, combined with the impact of stock incentive expenses, resulted in a year-on-year net profit decline of 16.4% and an adjusted net profit increase of 4% in Q3 2025 [4] Group 4: Long-term Growth Prospects - The company expects Glo Hilo to accelerate its global expansion in 2026, with concentrated shipments of HNB products likely to drive revenue growth. New products, technologies, and customers are anticipated to open up long-term opportunities [5] - In the vaping medical sector, the acceleration of complex generic drug development and the gradual realization of innovative drug collaborations are expected to lead to commercialization, providing long-term growth potential [5]

Core Viewpoint - The report from CICC indicates a downward adjustment in the net profit forecast for Smoore International (06969) for 2025 by 20% to 1.05 billion yuan, while the 2026 net profit forecast is raised by 11% to 1.88 billion yuan, reflecting a strong performance driven by HNB product sales [1] Group 1: Financial Performance - For the first three quarters of 2025, the company reported revenue of 10.21 billion yuan, a year-on-year increase of 21.8%, while the net profit attributable to shareholders was 810 million yuan, a year-on-year decrease of 23.8% [2] - Adjusted for stock incentive expenses, the net profit attributable to shareholders was 1.18 billion yuan, showing a slight year-on-year increase of 0.1% [2] - Quarterly net profit for 1Q, 2Q, and 3Q of 2025 was 200 million, 300 million, and 317 million yuan respectively, with year-on-year changes of -43.4%, +12.7%, and -16.4% [2] Group 2: Market Expansion and Product Performance - The Glo Hilo brand is expanding steadily in Japan and Poland, with the company positioned as a leader in flavor restoration, heating speed, and brand image [3] - The company anticipates continued growth in the European vaping market, driven by differentiated compliant products amid regulatory changes [3] - The open-system self-owned brand is leading in global market share, with expectations of continued year-on-year growth in 3Q25 [3] Group 3: Cost Structure and R&D Investment - Short-term profitability is impacted by the allocation of stock incentive expenses, while R&D investments remain high [4] - The company expects slight pressure on gross margins in the short term due to increased orders from small clients in the European vaping market and initial sales of HNB heating devices [4] - The net profit and adjusted net profit for 3Q25 showed year-on-year changes of -16.4% and +4% respectively [4] Group 4: Long-term Growth Prospects - The company is optimistic about the global expansion of HNB products, which is expected to drive performance in the coming years [5] - The combination of drug-device complex generic drug development and innovative drug collaborations is anticipated to lead to commercialization in the vaping medical sector, opening up long-term growth opportunities [5]

Core Viewpoint - Smoore International (06969) reported significant revenue growth in Q3 2025, reaching 4.197 billion yuan, a 27.2% year-on-year increase, but faced declining profitability with a net profit of 317 million yuan, down 16.4% year-on-year [1][10] Revenue Performance - The company achieved a record high quarterly revenue, with total revenue for the first three quarters of 2025 at 10.21 billion yuan, up 21.8% year-on-year [1] - Revenue growth was primarily driven by the enterprise client business and proprietary brand business, with overseas markets, particularly Europe and the US, contributing over 97% of revenue [1][4] Business Segments - Smoore International operates two main business segments: enterprise client business and proprietary brand business, both focusing on overseas markets, especially Europe [4] - The enterprise client business generated 2.734 billion yuan in Europe and other countries in the first half of 2025, a 38% increase, accounting for 57.7% of this segment's revenue [4] - The proprietary brand business saw revenue of 1.07 billion yuan in Europe and other countries, a 15.1% increase, contributing 84% of its segment revenue [4][5] Market Strategy - The company shifted its market strategy post-2022, focusing on overseas expansion after facing declines due to pandemic-related supply chain issues and domestic regulatory challenges [2] - The US and China markets showed weaker performance, with a 6.7% decline in the US proprietary brand revenue and only 0.5% revenue contribution from China [5] Research and Development - Smoore International invested heavily in R&D, with total R&D expenditure of 722 million yuan in the first half of 2025, focusing on electronic nicotine delivery systems [6][8] - The company holds a significant number of patents, with 839 new applications globally, ensuring a competitive edge in the electronic vaporization market [8] Profitability Challenges - The company's profitability is under pressure, with net profit margins declining from 20.67% in 2022 to 7.92% in the first three quarters of 2025 [9] - Increased R&D and operational costs have led to a rise in expense ratios, impacting overall profitability despite revenue growth [9] Market Outlook - Analysts have mixed views on Smoore International's future, with some predicting revenue growth driven by electronic cigarette sales but cautioning about declining net profits due to rising costs [10] - The company's growth potential hinges on regulatory conditions in key markets, with expectations for profitability to improve as overseas markets and new product lines continue to develop [10]